The US Food and Drug Administration review of the safety and effectiveness of nonstandardized allergen extracts  Jay E. Slater, MD, Sandra L. Menzies, MS, Jennifer Bridgewater, MPH, Alexis Mosquera, RN, MPH, Craig E. Zinderman, MD, MPH, Alan C. Ou, MD, MPH, Diane Maloney, JD, Catherine M. Cook, JD, Ronald L. Rabin, MD  Journal of Allergy and Clinical Immunology  Volume 129, Issue 4, Pages 1014-1019 (April 2012) DOI: 10.1016/j.jaci.2012.01.066 Copyright © 2012 Terms and Conditions

Fig 1 Adverse event reports associated with injection of allergen extracts by year from 1987 through mid 2010. The total number of adverse event reports received during this period was 178. Journal of Allergy and Clinical Immunology 2012 129, 1014-1019DOI: (10.1016/j.jaci.2012.01.066) Copyright © 2012 Terms and Conditions

Fig 2 Adverse events associated with injection of allergen extracts by allergen extract type. Note that some reports indicated more than 1 suspect product. Journal of Allergy and Clinical Immunology 2012 129, 1014-1019DOI: (10.1016/j.jaci.2012.01.066) Copyright © 2012 Terms and Conditions